CDKN1A and hepatocellular carcinoma: To determine whether CMTM6 is involved in the DNA damage-mediated regulation of p21, we treated the indicated cells with 0.2 μM Dox or 10 μM DDP, which are chemotherapeutic agents commonly used in TACE treatment for HCC, for 0, 8 and 16 h, separately.